Maureen Baker as Personal Representative of the Estate of Barnaby Dupuis Baker v. Oregon Health and Science University and Rodney F. Pommier, M.D.

CourtDistrict Court, D. Oregon
DecidedJanuary 5, 2026
Docket3:24-cv-00709
StatusUnknown

This text of Maureen Baker as Personal Representative of the Estate of Barnaby Dupuis Baker v. Oregon Health and Science University and Rodney F. Pommier, M.D. (Maureen Baker as Personal Representative of the Estate of Barnaby Dupuis Baker v. Oregon Health and Science University and Rodney F. Pommier, M.D.) is published on Counsel Stack Legal Research, covering District Court, D. Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Maureen Baker as Personal Representative of the Estate of Barnaby Dupuis Baker v. Oregon Health and Science University and Rodney F. Pommier, M.D., (D. Or. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF OREGON

MAUREEN BAKER as Personal Case No. 3:24-cv-709-SI Representative of the Estate of Barnaby Dupuis Baker, OPINION AND ORDER ON MOTIONS IN LIMINE AND OTHER Plaintiff, PRETIAL MATTERS v. OREGON HEALTH AND SCIENCE UNIVERSITY and RODNEY F. POMMIER, M.D., Defendants.

Benjamin T.G. Nivision and C.N. Coby Cohen, ROSSI VUCINOVICH PC, 1000 Second Avenue, Suite 1420, Seattle, Washington, 98104. Of Attorneys for Plaintiff.

Michael J. Wiswall and Taylor B. Lewis, HART WAGNER LLP, 1000 SW Broadway, Twentieth Floor, Portland, OR 97205. Of Attorneys for Defendants. Michael H. Simon, District Judge. The plaintiff in this diversity case is Maureen Baker, the widow of Mr. Barnaby Baker. She also is the personal representative of Mr. Baker’s estate. The two defendants are Oregon Health and Science University (“OHSU”) and Rodney Pommier, M.D., a surgeon. This is a medical negligence claim brought by the plaintiff on behalf of Mr. Baker’s estate. In March 2022, Mr. Baker was diagnosed with an abdominal wall hernia, and he consulted with Dr. Pommier regarding a hernia repair procedure. The hernia repair procedure occurred on April 27, 2022. During that procedure, Mr. Baker developed a change in cardiac rhythm and died. The plaintiff alleges that the defendants were negligent in their care of Mr. Baker because they failed to conduct a proper cardiac risk assessment and preoperative clearance for Mr. Baker before performing the hernia repair procedure. The plaintiff seeks noneconomic damages to

compensate the beneficiaries of the estate for the loss of society and companionship of Mr. Baker. The defendants deny that they were negligent in their care of Mr. Baker. The defendants assert that additional cardiac assessment was “not indicated” and that additional testing would not have revealed cardiac-related abnormalities or conditions and would not have prevented Mr. Baker’s death. Both OHSU and Dr. Pommier previously provided health care for Mr. Baker. In 2019, Mr. Baker was diagnosed with a small bowel neuroendocrine tumor, a rare type of cancer that develops in the neuroendocrine cells of the small intestine. Mr. Baker sought consultation with Dr. Pommier, a recognized authority in this type of cancer. In January 2020, more than two years

before Mr. Baker’s 2022 hernia surgery, Mr. Baker underwent an operation at OHSU. Dr. Pommier successfully performed this operation, and Mr. Baker did not have any further evidence of a neuroendocrine tumor. Mr. Baker was appropriately cared for and surveilled for his cancer by Dr. Pommier, who continued to monitor Mr. Baker. The parties, however, dispute the relevance and admissibility of Mr. Baker’s 2020 surgery. In March 2022, Mr. Baker developed left upper quadrant pain and a bulge and was diagnosed with an abdominal wall hernia. On April 4, 2022, Mr. Baker had a telemedicine visit with Dr. Pommier, who recommended that Mr. Baker have his hernia repaired before it caused a bowel obstruction. Dr. Pommier noted that Mr. Baker could have the procedure done in Seattle, but Mr. Baker wanted Dr. Pommier to perform that surgery. As discussed above, Mr. Baker did not survive his surgery. The Court has scheduled a nine-day jury trial to begin on January 12, 2026. On January 5, 2026, the Court held a final pretrial conference to discuss the parties’ motions in limine, objections to trial exhibits, objections to anticipated witness testimony, and other pretrial

matters. The Court now addresses these issues in this Opinion and Order. CUMULATIVE TIME LIMITS FOR WITNESS EXAMINATION The parties have requested, and the Court has set this matter for, a nine-day trial to a jury. The Court expects to be able to seat a jury before the lunch break on the first day of trial. The parties will then deliver opening statements after the Court gives the jury preliminary instructions. Based on the Court’s experience, this may leave about two hours at most for witness testimony on the first day of trial. Also based on the Court’s experience, about five hours of witness testimony can be received on each full trial day. The Court believes that this case could be completed within five days. Nevertheless, to ensure that this case will be in the hands of the jury not later than the eighth day of trial, which

will allow for deliberations on the ninth day, the Court will limit each side respectively to a total of 16 hours for all direct and cross examinations (including any redirect and recross examinations that may be allowed). During the final pretrial conference held on January 5, 2026, the Court discussed this time limit with the parties, and both sides stated that they do not object. The Court finds that this limit is both reasonable and sufficient for the parties’ needs. See Navellier v. Sletten, 262 F.3d 923, 941 (9th Cir. 2001) (“Trial courts have broad authority to impose reasonable time limits. Such limits are useful to prevent undue delay, waste of time, or needless presentation of cumulative evidence. While trial courts have discretion to expedite the completion of trials, they must not adhere so rigidly to time limits as to sacrifice justice in the name of efficiency.” (quotation marks and citations omitted)). Each party’s cumulative time limit does not include jury selection, opening statements, or closing arguments. The Court will monitor the parties’ time “chess clock style,” with a party’s time beginning when counsel begins to speak with a witness and ending when counsel concludes that portion of the examination. The Court may make appropriate adjustments for objections or sidebar conferences. The Court will

inform the parties at least daily of their respective consumed time. MOTIONS IN LIMINE A. Standards A motion in limine is “any motion, whether made before or during trial, to exclude anticipated prejudicial evidence before the evidence is actually offered.” Luce v. United States, 469 U.S. 38, 40 n.2 (1984); United States v. Heller, 551 F.3d 1108, 1111 (9th Cir. 2009) (stating that a motion in limine is a “procedural mechanism to limit in advance testimony or evidence in a particular area”). In addition, although a motion in limine is typically brought to exclude certain evidence at trial, on occasion a party may file a motion in limine seeking to admit certain evidence. This is not improper. See, e.g., Piper Aircraft Corp. v. Wag-Aero, Inc., 741 F.2d 925, 931 (7th Cir. 1984) (noting in a trademark case the “‘commendable procedure’ of submitting the

survey questions, along with the results of a preliminary survey, to the district court for a ruling in limine on the question of admissibility”). As with other motions raised before trial, motions in limine “are useful tools to resolve issues which would otherwise clutter up the trial.” City of Pomona v. SQM N. Am. Corp., 866 F.3d 1060, 1070 (9th Cir. 2017) (quotation marks omitted); see also Luce, 469 U.S. at 41 n.4 (explaining that a court may rule in limine “pursuant to the district court’s inherent authority to manage the course of trials”). Importantly, however, “a ruling on a motion in limine is essentially a preliminary opinion that falls entirely within the discretion of the district court. The district court may change its ruling at trial because testimony may bring facts to the district court’s attention that it did not anticipate at the time of its initial ruling.” Pomona, 866 F.3d at 1070 (quotation marks omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Erie Railroad v. Tompkins
304 U.S. 64 (Supreme Court, 1938)
Luce v. United States
469 U.S. 38 (Supreme Court, 1984)
Piper Aircraft Corporation v. Wag-Aero, Inc.
741 F.2d 925 (Seventh Circuit, 1984)
Piehl v. Dalles General Hospital
571 P.2d 149 (Oregon Supreme Court, 1977)
Townsend v. Kiracoff
545 F. Supp. 465 (D. Colorado, 1982)
United States v. Heller
551 F.3d 1108 (Ninth Circuit, 2009)
Jennison v. Providence St. Vincent Medical Center
25 P.3d 358 (Court of Appeals of Oregon, 2001)
City of Pomona v. Sqm North America Corp.
866 F.3d 1060 (Ninth Circuit, 2017)
State v. Tucker
768 P.2d 397 (Oregon Supreme Court, 1989)
United States v. Pacific Gas & Electric Co.
178 F. Supp. 3d 927 (N.D. California, 2016)
McConnell v. Wal-Mart Stores, Inc.
995 F. Supp. 2d 1164 (D. Nevada, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
Maureen Baker as Personal Representative of the Estate of Barnaby Dupuis Baker v. Oregon Health and Science University and Rodney F. Pommier, M.D., Counsel Stack Legal Research, https://law.counselstack.com/opinion/maureen-baker-as-personal-representative-of-the-estate-of-barnaby-dupuis-ord-2026.